Form 4 for ALLE Allegion
Accepted 2026-07-27 16:12:08 ET · period of report 2026-07-23 · accession 0001915220-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-27 16:12 | 2026-07-23 | ALLE | Wagnes Michael J. | SVP, CFO | M - OptEx | $78.79 | +3,184 | 32.8K | +11% | +$250.9K |
| DMT | 2026-07-27 16:12 | 2026-07-23 | ALLE | Wagnes Michael J. | SVP, CFO | S - Sale+OE | $150.98 | -3,184 | 31.3K | -9% | -$480.7K |
| DMT | 2026-07-27 16:12 | 2026-07-23 | ALLE | Wagnes Michael J. | SVP, CFO | M - OptEx | $0.00 | -3,184 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-23 | M | A | 1,716 | $71.83 | 33,015 | D | — | — | (F1) The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. |
| 2 | Common | Ordinary Shares | 2026-07-23 | S | D | 1,716 | $150.98 | 31,299 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. |
| 3 | Common | Ordinary Shares | 2026-07-23 | M | A | 1,468 | $86.93 | 32,767 | D | — | — | (F1) The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. |
| 4 | Common | Ordinary Shares | 2026-07-23 | S | D | 1,468 | $150.98 | 31,299 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-07-23 | M | D | 1,716 | $0.00 | 0 | D | $71.83 · — to 2027-02-13 | 1,716 Ordinary Shares | (F1) The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. (F3) A stock option that vested in equal annual installments on February 13, 2018, February 13, 2019, and February 13, 2020, and is exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-07-23 | M | D | 1,468 | $0.00 | 0 | D | $86.93 · — to 2028-02-22 | 1,468 Ordinary Shares | (F1) The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. (F4) A stock option that vested in equal annual installments on February 22, 2019, February 22, 2020, and February 22, 2021, and is exercisable. |